Markets:

Overview

News

Currencies

International

Treasuries

Biogen Idec (NQ:BIIB)

192.03 -0.05 (-0.03%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Biogen Idec

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

48 49 Next >

What In The World Is Going On With Biogen (BIIB) Shares? ↗

September 28, 2022

Biogen Inc (NASDAQ: BIIB) shares are trading higher by 42.62% to $282.08 during Wednesday's pre-market session after the company and Eisai Co.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

September 28, 2022

It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning.

Via InvestorPlace

Why Cassava Sciences Shares Are Soaring Higher ↗

September 28, 2022

Cassava Sciences Inc (NASDAQ: SAVA) shares are trading higher by 7.15 to $49.48 during Wednesday's pre-market session after Biogen Inc (NASDAQ: BIIB) and Eisai Co.

Via Benzinga

What's Going On With Eli Lilly Stock Shooting Higher Today ↗

September 28, 2022

Eli Lilly And Co (NYSE: LLY) shares are trading higher by 7.60% to $334.75 during Wednesday's pre-market session after Biogen Inc (NASDAQ: BIIB) and Eisai Co.

Via Benzinga

Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket ↗

September 28, 2022

Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday.

Via Benzinga

Biogen Settles For $900M In Bribe Case For Prescribing Multiple Sclerosis Drugs ↗

September 27, 2022

Via Benzinga

Nasdaq Futures Slip But S&P 500, Dow Futures Hold Up Ahead Of Market Open — Apple, Biogen Stocks In Focus ↗

September 28, 2022

U.S. stocks could struggle for direction on Wednesday after the market struggled en route to a mixed close in the previous session. Volatility could be the order of the day as another batch of Fed...

Via Benzinga

Why Biogen Stock Is Up 40% Today ↗

September 28, 2022

Biogen, Inc. (NASDAQ: BIIB) shares are soaring over 43% to their highest level in about a year in premarket trading Wednesday.

Via Benzinga

Biogen, Eli Lilly And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

September 28, 2022

U.S. stock futures traded lower this morning. Here are some big stocks moving higher in today’s pre-market trading session.

Via Benzinga

2 Sympathy Plays To Watch For In The Wake Of Biogen's Positive Alzheimer's Drug Data ↗

September 28, 2022

Biogen Inc. (NASDAQ: BIIB) and partner Eisai Co. Ltd.

Via Benzinga

US Stock Futures Down Ahead Of Fed Speakers, Economic Data ↗

September 28, 2022

Pre-open movers U.S. stock futures traded lower in early pre-market trade on Wednesday after closing mostly lower on Tuesday. The S&P 500 index dropped deeper into a bear market after hitting a fresh...

Via Benzinga

What Are Whales Doing With Biogen ↗

September 12, 2022

A whale with a lot of money to spend has taken a noticeably bearish stance on Biogen. Looking at options history for Biogen (NASDAQ:BIIB) we detected 28 strange trades.

Via Benzinga

Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock ↗

September 28, 2022

Biogen, Inc. (NASDAQ: BIIB) and Eisai Co. Ltd. (OTC: ESALY) announced late Tuesday positive results from a late-stage study of their Alzheimer’s treatment candidate.

Via Benzinga

Check Out What Whales Are Doing With BIIB ↗

September 27, 2022

A whale with a lot of money to spend has taken a noticeably bullish stance on Biogen. Looking at options history for Biogen (NASDAQ:BIIB) we detected 19 strange trades.

Via Benzinga

Elon Musk Twitter Case Deposition Delayed, FTX US Goes Shopping, Spotify's Analyst Sees Audiobooks Immaterial: Top Financial Media Stories Tuesday, Sept. 27 ↗

September 27, 2022

Bloomberg

Via Benzinga

The 'Transformative' Eli Lilly Drug That Could Top $25 Billion In Annual Sales ↗

September 22, 2022

The drug already has one FDA approval as Lilly angles for a second.

Via Investor's Business Daily

Novavax Price Target Cut By Around 80%, Plus This Analyst Predicts $129 For NIKE ↗

September 22, 2022

Morgan Stanley cut the price target for NIKE, Inc. (NYSE: NKE) from $149 to $129. NIKE shares fell 0.6% to $99.20 on Thursday.

Via Benzinga

Longer-Term Use, Early Initiation of Biogen's Experimental Drug For Inherited Rare Disease Slows Disease Progression ↗

September 22, 2022

Via Benzinga

Looking At Biogen's Recent Whale Trades ↗

September 20, 2022

Someone with a lot of money to spend has taken a bearish stance on Biogen (NASDAQ:BIIB). And retail traders should know. We noticed this today when the big position showed up on publicly available...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

September 15, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin ↗

September 15, 2022

The market is struggling, yet biotech stocks are acting like it's good times again. Here's why.

Via Investor's Business Daily

Biogen Whale Trades For September 14 ↗

September 14, 2022

Someone with a lot of money to spend has taken a bearish stance on Biogen (NASDAQ:BIIB). And retail traders should know. We noticed this today when the big position showed up on publicly available...

Via Benzinga

Hurry! It’s Time to Take Your Profits From These 7 Stocks ↗

September 13, 2022

Investors are increasingly focused on stocks to sell as they brace for a tough September as the economy's challenges mount.

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

September 13, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Biotech Stocks Stand to Benefit as Biden Announces Support for Industry ↗

September 12, 2022

President Biden has announced a new initiative to help U.S. biotech producers grow. Here's what this news means for biotech stocks.

Via InvestorPlace

Expert Ratings for Biogen ↗

September 12, 2022

Over the past 3 months, 6 analysts have published their opinion on Biogen (NASDAQ:BIIB) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's...

Via Benzinga

Has The Controversy Around Falsified Alzheimer's Research Impacted The Path To Finding The Cure? ↗

September 07, 2022

Finding the cure to Alzheimer’s has confounded researchers for decades. As a disease, Alzheimer’s is highly complex and has a wide range of symptoms, including sleeplessness, wandering, agitation,...

Via Benzinga

Insider Richard Barry Is Betting Big on Cassava (SAVA) Stock ↗

August 26, 2022

Cassava is reaching the end of its study on Simufilam, an Alzheimer's treatment, and a third insider just bought shares of SAVA stock.

Via InvestorPlace

7 F-Rated Stocks to Avoid Now ↗

August 12, 2022

The following equities may be household names, but current market conditions mean they’re definitely stocks to avoid now.

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 12, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

48 49 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Biogen Idec (NQ:BIIB)

Headline News about Biogen Idec

Starting at $3.75/week.

Subscribe Today